ZYVERSA THERAPEUTICS, INC. Conversion of Stock, Shares Issued
ZYVERSA THERAPEUTICS, INC. (ZVSA) reported Conversion of Stock, Shares Issued of 6.72 million shares for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesIssued1 · last filed 2024-03-25
- ZYVERSA THERAPEUTICS, INC. conversion of stock, shares issued for fiscal 2022 was 6.72M shares.
| Period end | Conversion of Stock, Shares Issued 1 month | Conversion of Stock, Shares Issued 12 month |
|---|---|---|
| 2022-12-31 | 191.99K shares 10-K · filed 2024-03-25 | 6.72M shares 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |